Remotely Triggered Nano-Theranostics For Cancer Applications
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Nanotechnology has enabled the development of smart theranostic platforms that can concurrently diagnose disease, start primary treatment, monitor response, and, if required, initiate secondary treatments.Recent in vivo experiments demonstrate the promise of using theranostics in the clinic.In this paper, we review the use of remotely triggered theranostic nanoparticles for cancer applications, focusing heavily on advances in the past five years.Remote triggering mechanisms covered include photodynamic, photothermal, phototriggered chemotherapeutic release, ultrasound, electro-thermal, magneto-thermal, X-ray, and radiofrequency therapies.Each section includes a brief overview of the triggering mechanism and summarizes the variety of nanoparticles employed in each method.Emphasis in each category is placed on nano-theranostics with in vivo success.Some of the nanotheranostic platforms highlighted include photoactivatable multi-inhibitor nanoliposomes, plasmonic nanobubbles, reduced graphene oxide-iron oxide nanoparticles, photoswitching nanoparticles, multispectral optoacoustic tomography using indocyanine green, low temperature sensitive liposomes, and receptor-targeted iron oxide nanoparticles loaded with gemcitabine.The studies reviewed here provide strong evidence that the field of nanotheranostics is rapidly evolving.Such nanoplatforms may soon enable unique advances in the clinical management of cancer.However, reproducibility in the synthesis procedures of such "smart" platforms that lend themselves to easy scale-up in their manufacturing, as well as the development of new and improved models of cancer that are more predictive of human responses, need to happen soon for this field to make a rapid clinical impact.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Light‐sensitive Intelligent Drug Delivery Systems†
Alvarez‐Lorenzo, C., Bromberg, L., & Concheiro, A. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00530.x · Cited by 519 · cited 1×
“For example, the laser causes an irrevocable physical change in the system that incites a “burst” release of the payload, while others experience reversible structural changes when the laser is turned off/on and act as multi-controllable systems that release the payload in a pulsatile, on-demand routine [77].”
Surface-enhanced resonance Raman scattering nanostars for high-precision cancer imaging
Harmsen, S., Huang, R., Wall, M. A., Karabeber, H., Samii, J. M., Spaliviero, M., White, J. R., Monette, S., O’Connor, R., Pitter, K. L., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010633 · Cited by 296
Ranjan, A., Jacobs, G. C., Woods, D. L., Negussie, A. H., Partanen, A., Yarmolenko, P. S., Gacchina, C. E., Sharma, K. V., Frenkel, V., Wood, B. J., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.011 · Cited by 267 · cited 7×
“In one such study, low temperature sensitive liposomes (LTSLs) loaded with chemotherapeutic drug, doxorubicin (DOX), were investigated for image-guided treatment in rabbits [114].”
Influential
Cited by
Nanotheranostics: Emerging Strategies for Early Diagnosis and Therapy of Brain Cancer
Sonali, Viswanadh, M. K., Singh, R. P., Agrawal, P., Mehata, A. K., Pawde, D. M., Narendra, Sonkar, R., & Muthu, M. S. (2018) · Nanotheranostics · doi:10.7150/ntno.21638 · Cited by 169
“Finally, nanotheranostics which target molecular biomarkers of brain cancer with advanced designs are likely to contribute to the early diagnosis and therapy of brain cancer [138, 139].”
BackgroundRecent advances in theranostic polymeric nanoparticles for cancer treatment: A review
Indoria, S., Singh, V., & Hsieh, M.-F. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119314 · Cited by 168
Beygi, M., Oroojalian, F., Hosseini, S. S., Mokhtarzadeh, A., Kesharwani, P., & Sahebkar, A. (2023) · Progress in Materials Science · doi:10.1016/j.pmatsci.2023.101209 · Cited by 32
RetractedSalarvand, A., Shanei, A., Hejazi, S. H., Abedi, I., & Kakhki, N. A. (2025) · Advanced Biomedical Research · doi:10.4103/abr.abr_221_24 · Cited by 5
“[24,25] In the present study, a set of combined Gem and gold nanoparticles has been developed as a chemoradiotherapy sensitizer, and after that, the effectiveness of this sensitizer has been evaluated through in vitro experiments.”
Metadata
- Authors
- Sneider, A., VanDyke, D., Paliwal, S., & Rai, P.
- Venue
- Nanotheranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2017
- Volume
- 1
- Issue
- 1
- Pages
- 1-22
- ISSN
- 2206-7418 (ISSN-L)
- OpenAlex
- W2564285545
- Cited by
- 108
- References
- 3
- FWCI
- 7.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.